ABCL

3.86

2.66% 0.10

Handel nachbörslich: 3.85 -0.010 -0.26%

Abcellera Biologics Inc (ABCL)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt ABCL? Forum Prognose

Schlusskurs vom Vortag:

$3.76

Offen:

$3.77

24-Stunden-Volumen:

2.98M

Relative Volume:

0.81

Marktkapitalisierung:

$1.17B

Einnahmen:

$75.13M

Nettoeinkommen (Verlust:

$-146.41M

KGV:

-7.8711

EPS:

-0.4904

Netto-Cashflow:

$-174.43M

1W Leistung:

+12.54%

1M Leistung:

+10.60%

6M Leistung:

-36.72%

1J Leistung:

+58.85%

1-Tages-Spanne:

$3.77

$3.90

1-Wochen-Bereich:

$3.37

$3.90

52-Wochen-Spanne:

$1.94

$6.515

Abcellera Biologics Inc Stock (ABCL) Company Profile

Firmenname

Abcellera Biologics Inc

Sektor

Healthcare (1112)

Branche

Biotechnology (621)

Telefon

(604) 559-9005

Adresse

150 W 4TH AVENUE, VANCOUVER

Mitarbeiter

562

Twitter

Nächster Verdiensttermin

2024-11-18

Neueste SEC-Einreichungen

ABCL's Discussions on Twitter

Compare ABCL vs VRTX, REGN, ARGX, ALNY, ONC

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
ABCL Abcellera Biologics Inc	3.86	1.14B	75.13M	-146.41M	-174.43M	-0.4904
VRTX Vertex Pharmaceuticals Inc	441.70	113.01B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	753.93	79.87B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	840.87	51.51B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	333.39	45.29B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	319.94	34.41B	5.36B	287.73M	924.18M	2.5229

Abcellera Biologics Inc Stock (ABCL) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-11-07	Herabstufung	Leerink Partners	Outperform → Market Perform
2025-07-07	Fortgesetzt	Leerink Partners	Outperform
2024-08-20	Herabstufung	The Benchmark Company	Buy → Hold
2024-02-22	Hochstufung	The Benchmark Company	Hold → Buy
2023-12-05	Eingeleitet	KeyBanc Capital Markets	Overweight
2023-11-06	Herabstufung	The Benchmark Company	Buy → Hold
2023-10-13	Fortgesetzt	Piper Sandler	Overweight
2023-02-28	Eingeleitet	Cowen	Outperform
2022-12-15	Eingeleitet	Goldman	Buy
2022-11-16	Eingeleitet	Truist	Buy
2021-12-21	Eingeleitet	The Benchmark Company	Buy
2021-11-19	Eingeleitet	Piper Sandler	Overweight
2021-01-05	Eingeleitet	BMO Capital Markets	Outperform
2021-01-05	Eingeleitet	Berenberg	Buy
2021-01-05	Eingeleitet	Credit Suisse	Outperform
2021-01-05	Eingeleitet	SVB Leerink	Outperform
2021-01-05	Eingeleitet	Stifel	Buy

Alle ansehen

Abcellera Biologics Inc Aktie (ABCL) Neueste Nachrichten

11:08 AM

Truist reiterates Buy on AbCellera stock, eyes 2H26 data readout By Investing.com - Investing.com Canada

11:08 AM

11:00 AM

Truist reiterates Buy on AbCellera stock ahead of 2H26 data - Investing.com

11:00 AM

10:56 AM

Truist reiterates Buy on AbCellera stock ahead of 2H26 data By Investing.com - Investing.com Canada

10:56 AM

10:54 AM

Truist reiterates Buy on AbCellera stock, eyes 2H26 data readout - Investing.com

10:54 AM

Apr 14, 2026

Biotech Penny Stocks Rally OABI ABCL PACB 2026 - Gotrade

Apr 14, 2026

Is Jones Trading’s New Coverage of AbCellera (ABCL) Reframing Its Clinical-Stage Platform Narrative? - Yahoo Finance

Apr 14, 2026

AbCellera Biologics (ABCL) Committed to Leverage Differentiated Technology for Drug Discovery - Insider Monkey

Apr 14, 2026

Apr 13, 2026

Is AbCellera Biologics Inc affected by consumer sentimentWall Street Watch & Free High Return Stock Watch Alerts - baoquankhu1.vn

Apr 13, 2026

Wall Street Bullish on AbCellera Biologics Inc. (ABCL), Here’s Why - MSN

Apr 13, 2026

Portfolio Recap: Is AbCellera Biologics Inc part of any ETFMarket Activity Summary & Precise Swing Trade Alerts - baoquankhu1.vn

Apr 13, 2026

Apr 11, 2026

Insider Sell: What hedge funds are buying AbCellera Biologics Inc2026 Fundamental Recap & Fast Entry High Yield Stock Tips - baoquankhu1.vn

Apr 11, 2026

AbCellera Biologics Inc (HAM:8QQ) Stock Price & 30 Year Financial Data - GuruFocus

Apr 11, 2026

Apr 10, 2026

AbCellera Biologics (ABCL): New 'Buy' Rating from Jones Trading | ABCL Stock News - GuruFocus

Apr 10, 2026

Jones Trading initiates coverage of AbCellera Biologics (ABCL) with buy recommendation - MSN

Apr 10, 2026

Apr 09, 2026

JonesTrading Initiates AbCellera Biologics(ABCL.US) With Buy Rating, Announces Target Price $11 - Moomoo

Apr 09, 2026

ABCL News | ABCELLERA BIOLOGICS INC (NASDAQ:ABCL) - ChartMill

Apr 09, 2026

Apr 07, 2026

Aug Big Picture: What is AbCellera Biologics Incs P E ratio telling usTrade Ideas & Accurate Buy Signal Notifications - baoquankhu1.vn

Apr 07, 2026

Apr 06, 2026

Insider Stock Buying Reaches US$1.04m On AbCellera Biologics - Moomoo

Apr 06, 2026

Truist Financial Maintains AbCellera Biologics(ABCL.US) With Buy Rating, Announces Target Price $3.52 - Moomoo

Apr 06, 2026

Press Releases about AbCellera Biologics Inc.Common Shares (Nasdaq:ABCL) - FinancialContent

Apr 06, 2026

ABCL Technical Analysis | Trend, Signals & Chart Patterns | ABCELLERA BIOLOGICS INC (NASDAQ:ABCL) - ChartMill

Apr 06, 2026

Apr 05, 2026

What sparked AbCellera Biologics to soar over 9% after hours - MSN

Apr 05, 2026

Apr 03, 2026